Compare TBBK & NEOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TBBK | NEOG |
|---|---|---|
| Founded | 1999 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 1.9B |
| IPO Year | 2005 | 1995 |
| Metric | TBBK | NEOG |
|---|---|---|
| Price | $59.56 | $9.59 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 4 |
| Target Price | ★ $69.00 | $10.67 |
| AVG Volume (30 Days) | 420.5K | ★ 2.5M |
| Earning Date | 04-23-2026 | 04-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 14.69 | N/A |
| EPS | ★ 4.92 | 0.02 |
| Revenue | $141,147,000.00 | ★ $894,661,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $8.16 | $1.67 |
| P/E Ratio | ★ $12.09 | $458.25 |
| Revenue Growth | ★ 20.85 | N/A |
| 52 Week Low | $42.86 | $4.32 |
| 52 Week High | $81.65 | $11.43 |
| Indicator | TBBK | NEOG |
|---|---|---|
| Relative Strength Index (RSI) | 67.89 | 50.53 |
| Support Level | $50.85 | $8.93 |
| Resistance Level | $71.63 | $10.30 |
| Average True Range (ATR) | 1.67 | 0.52 |
| MACD | 0.90 | 0.07 |
| Stochastic Oscillator | 93.49 | 44.32 |
The Bancorp Inc is a financial holding company. The Company's operations are classified under three segments: fintech, Credit Solutions (three sub-segments), and corporate. The fintech segment includes the deposit balances and non-interest income generated by prepaid, debit, and other card-accessed accounts, ACH processing, and other payments-related processing. It also includes loan balances and interest and non-interest income from credit products generated through payment relationships; Credit Solutions includes REBL (real estate bridge lending), comprised of apartment building rehabilitation loans, and Others; Corporate includes the Company's investment securities, corporate overhead, and expenses which have not been allocated to segments.
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, the company performs diagnostics to detect unintended substances in food and animal feed, to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. In animal safety, the company segment is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services.